1 – 5 of 5
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Development and validation of a patient-reported outcome measure for systemic sclerosis : the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
(
- Contribution to journal › Article
- 2018
-
Mark
There is a need for new systemic sclerosis subset criteria. A content analytic approach
(
- Contribution to journal › Article
- 2017
-
Mark
The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease : A multicentre European Scleroderma Trials and Research group (EUSTAR) study
(
- Contribution to journal › Article
-
Mark
Update of EULAR recommendations for the treatment of systemic sclerosis
(
- Contribution to journal › Article
- 2016
-
Mark
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
(
- Contribution to journal › Article